Ranitidine clinical uses
Pro Research Analysisby 
Searched over 200M research papers
Ranitidine Clinical Uses: Acid Suppression and Gastrointestinal Disorders
Ranitidine is a histamine H2-receptor antagonist that effectively reduces gastric acid and pepsin secretion. It is more potent than cimetidine and achieves strong acid inhibition when administered at standard doses, such as 150 mg twice daily . This makes ranitidine a key treatment for conditions where acid suppression is needed.
Treatment of Gastritis, GERD, and Reflux Esophagitis
Ranitidine is widely used to manage gastritis and gastroesophageal reflux disease (GERD) in both adults and children. It acts quickly and is often preferred for on-demand use, especially in pediatric patients, due to its rapid onset and favorable safety profile compared to proton pump inhibitors (PPIs) . In adults, ranitidine has been shown to significantly improve symptoms like heartburn and regurgitation and to promote healing of endoscopic lesions in reflux esophagitis . It is also effective in preventing nocturnal acid reflux .
Prevention of Stress-Induced Gastric Lesions and Postoperative Complications
Ranitidine is used to prevent stress-induced gastric lesions, particularly in critically ill pediatric patients . In high-risk neurosurgical patients, ranitidine significantly reduces the incidence of postoperative gastroduodenal complications such as bleeding and perforation, making it valuable for surgical prophylaxis . It also helps reduce gastric fluid volume when used as preoperative prophylaxis .
Use in Malignant Bowel Obstruction (MBO) in Palliative Care
In palliative care, especially for adults with malignant bowel obstruction, ranitidine is used as an antisecretory medication to reduce gastrointestinal secretions. While not always the first-line agent, it is commonly administered via continuous subcutaneous infusion for acid-related symptoms, often in combination with other medications, and is considered when other treatments fail .
Pediatric Applications and Safety
Ranitidine is considered a safe and effective option for short-term acid suppression in children, with recommendations supporting its use for gastritis, GERD, and stress ulcer prevention. It is often chosen over PPIs for its safety and rapid action .
Emerging and Experimental Uses
Research in animal models suggests that ranitidine may have potential as an adjuvant therapy in cancer, particularly breast cancer, by modifying immune cell populations and reducing tumor growth and spread . Additionally, a related compound, ranitidine bismuth citrate, has shown promise in suppressing SARS-CoV-2 replication and relieving virus-associated pneumonia in preclinical studies, though this is not a standard clinical use for ranitidine itself .
Conclusion
Ranitidine is primarily used for acid suppression in conditions such as gastritis, GERD, reflux esophagitis, and for the prevention of stress-induced gastric lesions and postoperative complications. It is also utilized in palliative care for malignant bowel obstruction and is considered safe for pediatric use. While new research points to possible roles in cancer therapy and viral infections, these uses remain experimental. Overall, ranitidine remains a versatile and effective medication for a range of gastrointestinal disorders Dawson1983Pai2022Vila-Leahey2016+4 MORE.
Sources and full results
Most relevant research papers on this topic
Ranitidine use in pediatrics: current evidence-based review and recommendations
Ranitidine is a better and safer alternative to proton pump inhibitors for short-term acid suppression in pediatrics for treating gastritis, GERD, and preventing nocturnal acid reflux.
Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice
Ranitidine reduces myeloid-derived suppressor cells and inhibits breast tumor development and spread in mice, offering potential as an adjuvant therapy or preventative agent in breast cancer.
183 How are specialist palliative care units using ranitidine in the medical management of adults with malignant bowel obstruction? A survey of UK hospices
Ranitidine is used by most UK hospices for selected adults with malignant bowel obstruction, despite a limited evidence base.
Treatment of reflux oesophagitis with ranitidine.
Ranitidine effectively improves heartburn and regurgitation symptoms and heals endoscopic lesions in patients with moderate to severe reflux oesophagitis, with no significant side effects or biochemical changes.
Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters
Ranitidine bismuth citrate, a common drug for treating Helicobacter pylori infection, shows potential as a potent anti-SARS-CoV-2 agent and relieves virus-associated pneumonia in Syrian hamsters.
Prospective double-blind placebo-controlled randomized trial on the use of ranitidine in preventing postoperative gastroduodenal complications in high-risk neurosurgical patients.
Ranitidine effectively reduces the incidence of postoperative gastroduodenal complications in high-risk neurosurgical patients.
Effectiveness Of Ranitidine Providing Compared With Omeprazol In Children With Gastroesofageal Reflux Disease
Omeprazole is likely to be more effective than ranitidine for complete symptom relief in children with gastroesophageal reflux disease.
DOI